Former NFL pro Chris Maragos wins $43.5 million medical malpractice claim

Published Date: 02 Mar 2023

The legal team said the jury's decision could make medics think twice before allowing the injured to return to the field.

Read Full News

Latest News

GSK, Hansoh's Bone Cancer Drug Meets Main Goal in Late-stage Trial

GSK on Tuesday said partner Hansoh Pharmaceutical's experimental drug met the main goal ⁠of keeping an aggressive bone cancer from worsening in a late-stage trial, boosting...

Liberalized Diet Fails to Match Neutropenic Safety

Dr Maurie Markman discusses why modifying cancer diets without RCT data poses major risks, highlighting a trial halted due to a 10% spike in serious infections.

Chordoma Guidance Moves Into Age of Shared Decision-Making

A consensus update for chordoma 11 years in the making focuses on a multidisciplinary approach, use of biomarkers and lays out site-specific protocols.

FDA Expands Pembrolizumab-Enfortumab Vedotin Regimen in MIBC

Pembrolizumab plus enfortumab vedotin is now approved for all adults with muscle-invasive bladder cancer undergoing cystectomy.

AI Tool Offers Early Warning System for Drug Shortages

A new platform developed by researchers at the University of Toronto uses real-world data and AI-enabled forecasting to identify medications that may soon be in short supply.

Amplify, Apply, Advance: Bridging Academic Expertise and Community Practice to Elevate CML Care

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Latest News

GSK on Tuesday said partner Hansoh Pharmaceutical's experimental drug met the main goal ⁠of keeping an aggressive bone cancer from worsening in a late-stage trial, boosting...

Dr Maurie Markman discusses why modifying cancer diets without RCT data poses major risks, highlighting a trial halted due to a 10% spike in serious infections.

A consensus update for chordoma 11 years in the making focuses on a multidisciplinary approach, use of biomarkers and lays out site-specific protocols.

Pembrolizumab plus enfortumab vedotin is now approved for all adults with muscle-invasive bladder cancer undergoing cystectomy.

A new platform developed by researchers at the University of Toronto uses real-world data and AI-enabled forecasting to identify medications that may soon be in short supply.

Amplify, Apply, Advance: Bridging Academic Expertise and Community Practice to Elevate CML Care

News All Time

Aesthetic Medicine

Aesthetic Medicine : The Aesthetic Medicine News & Perspectives presents the latest information on anti-aging treatments, injectable and implantable soft tissue fillers, botulinum toxin treatments, laser surgery, and other treatments to repair and improve the function and cosmetic appearance of skin tissue.

PET-CT Linked to Improved Margin Assessment in Breast Cancer

Researchers compare success rates for addressing positive margins without intraoperative margin assessment with specimen PET-CT in patients with invasive ductal carcinoma.

Water Ablation Shows Early Promise for Prostate Cancer

Early findings show efficacy of water vapor therapy for treating intermediate-risk prostate cancer with minimal procedural complications.

Vacuum-Tech May Improve Outcomes of Kidney Stone Surgery

Vacuum-assisted flexible ureteroscopy may help clear large kidney stones as well as or better than mainstay treatments, with favorable outcomes after surgery.

Patient Requests That Can Put You In a Tough Position

Requests for emotional support animals, disabled parking placards, and, more recently, Medicaid work exemptions can prove challenging for physicians. Here’s what you need to know.

Europe’s Medical Loophole for Banned Doctors

A doctor struck off in France kept practicing in Belgium, exposing how gaps in EU medical oversight can let sanctioned clinicians cross borders.

Rare Adenoid Cystic Breast Cancer in a Woman

A woman with rare breast adenoid cystic carcinoma carries a BRIP1 variant of uncertain significance, highlighting the challenges in genetic risk assessment.

What the FDA's Hormone Therapy Decision Means for Aging Skin

Skin collagen content decreases at a rate of approximately 1%-2% per year in the early postmenopausal period, skin thickness diminishes, barrier function weakens, and moisture retention falters

US FDA Approves Pfizer's Bleeding Disorder Drug for Children

(Corrects paragraph 2 to say Hympavzi is the first non-factor therapy particularly for pediatric patients with hemophilia ⁠B, not all)

Ask the HF Expert: Advanced Therapies

Dr Yash Varma, a chief cardiology fellow, asks Dr Ileana Piña for her insights on when a patient with heart failure should be referred for advanced therapies.

Tile-Based Radiation to Treat Large Brain Metastases?

The GammaTile may improve outcomes over standard stereotactic RT after resection of large brain metastases, but a striking overall survival benefit in a phase 3 trial raises questions.

Selpercatinib Cuts Recurrence Risk in Early RET+ NSCLC

In the first phase 3 trial of a RET inhibitor as adjuvant therapy, selpercatinib markedly improved event-free survival vs placebo in early-stage RET fusion-positive NSCLC.

More Women With Breast Cancer Can Skip Axillary Dissection

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.

Will PROTEUS Change the Playbook for Radical Prostatectomy?

New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

S1 Episode 4: Managing Heart Failure in ATTR-CM

From narrow volume windows to SGLT2 inhibitors and emerging devices, Drs Kevin Alexander and Sarah Cuddy discuss heart failure care in ATTR-CM.

Coconut Oil

Current evidence supports the use of this botanical agent to promote skin health, but more research is needed to ascertain more varied and curative applications for this popular natural product.